CORRECTION: ENDRA Life Sciences Prices $8M Public Offering Of 61,538,461 Shares Of Common Stock And Accompanying Series A And Series B Warrants At A Combined Purchase Price Of $0.13
Portfolio Pulse from Benzinga Newsdesk
ENDRA Life Sciences has announced the pricing of an $8 million public offering, which includes 61,538,461 shares of common stock and accompanying Series A and Series B warrants at a combined purchase price of $0.13.
June 04, 2024 | 1:28 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ENDRA Life Sciences has priced an $8 million public offering, issuing 61,538,461 shares of common stock and accompanying Series A and Series B warrants at a combined purchase price of $0.13.
The issuance of a large number of shares at a low price could dilute existing shareholders' value, potentially leading to a short-term decrease in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100